セリンプロテインキナーゼの世界市場（2022年～2028年）

世界のセリンプロテインキナーゼの市場規模は、予測期間中にかなりのCAGRで成長すると予測されています。当市場を牽引する主な要因には、がん疾患の増加や、低分子プロテインキナーゼ阻害剤に対する米国FDAの承認などがあります。

当レポートでは、世界のセリンプロテインキナーゼ市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、セグメント別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向

第3章 競合情勢

• Eli Lilly and Co
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• AstraZeneca plc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Merck KGaA
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Bayer AG
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Pfizer Inc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析
• COVID-19が主要企業に与える影響

第4章 市場セグメンテーション

• タイプ別
  • AZD-0156
  • AZD-1390
  • KU-55933
  • M-3541
  • その他
• 用途別
  • がん
  • 腺がん
  • その他

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Bristol-Myers Squibb Company
• CanBas Co Ltd
• Cascadian Therapeutics Inc
• CytRx Corporation
• Eisai Co Ltd
• F. Hoffmann-La Roche Ltd
• Genentech Inc
• InteRNA Technologies B.V.
• Johnson & Johnson Pvt Ltd
• Novartis AG
• Osi Pharmaceutical Inc
• ProNAi Therapeutics Inc
• Sareum Holdings Plc
• Shuttle Pharmaceutical LLC
• Vernalis Plc

LIST OF TABLES

• 1. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 2. GLOBAL AZD-0156 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 3. GLOBAL AZD-1390 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 4. GLOBAL KU-55933 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 5. GLOBAL M-3541 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 6. GLOBAL OTHER SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 7. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 8. GLOBAL SERINE PROTEIN KINASE IN CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 9. GLOBAL SERINE PROTEIN KINASE IN ADENOCARCINOMA MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 10. GLOBAL SERINE PROTEIN KINASE IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 11. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
• 12. NORTH AMERICAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 13. NORTH AMERICAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 14. EUROPEAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 15. EUROPEAN SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 16. ASIA-PACIFIC SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 17. ASIA-PACIFIC SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
• 18. REST OF THE WORLD SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 19. REST OF THE WORLD SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL SERINE PROTEIN KINASE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 (%)
• 4. GLOBAL SERINE PROTEIN KINASE MARKET SHARE BY TYPE, 2021 VS 2028(%)
• 5. GLOBAL AZD-0156 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 6. GLOBAL AZD-1390 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 7. GLOBALKU-55933 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 8. GLOBAL M-3541 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 9. GLOBAL OTHERS SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 10. GLOBAL SERINE PROTEIN KINASE MARKET BY APPLICATION, 2021 VS 2028(%)
• 11. GLOBAL CANCER SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 12. GLOBAL ADENOCARCINOMA SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 13. GLOBAL OTHERS SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
• 14. GLOBAL SERINE PROTEIN KINASE MARKET BY GEOGRAPHY, 2021 VS 2028(%)
• 15. US GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 16. CANADA GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 17. UK GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 18. FRANCE GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
• 19. GERMANY GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 20. ITALY GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 21. SPAIN GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 22. REST OF EUROPE GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 23. INDIA GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
• 24. CHINA GLOBAL SERINE PROTEIN KINASEMARKET SIZE, 2021-2028 ($ MILLION)
• 25. JAPAN GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
• 26. SOUTH KOREA GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 27. REST OF ASIA-PACIFIC GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
• 28. REST OF THE WORLD GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)

Global Serine Protein Kinase Market Size, Share and Trends Analysis Report, By Type (AZD-0156, AZD-1390, KU-55933, M-3541, and Others), By Application (Cancer, Adenocarcinoma, and Others), Forecast (2022-2028)

The global serine protein kinase market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). In the modern medical research landscape, protein kinase is one of the most important categories of targets in drug discovery. According to the National Cancer Institute (NCI), there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Apart from these, the US FDA approvals to small molecule protein kinase inhibitors are the other prominent factor that has surged the market growth. For instance, the US FDA approved four small molecule protein kinase antagonists in 2019; these include entrectinib, erdafitinib, pexidartinib, and fedratinib. In addition, the funding raised by the pharmaceutical companies for further R&D for kinase inhibitors can considered as a driving factor in market growth. For instance, in August 2020 Kinnate Biopharma announced that it has raised $98 million and the company will be utilizing it to push its kinase inhibitors pipeline to develop targeted therapies for cancer treatment.

The global serine protein market is segmented based on the type and based on application. Based on the type the market is sub-segmented into AZD-0156, AZD-1390, KU-55933, M-3541, and others. Based on the application the market is sub-segmented into cancer, adenocarcinoma, and others. Among these, cancer segment is projected to be the fastest growing segment during the forecast owing to the increasing cancer prevalence among population globally dur to which the demand for kinase inhibitors for treatment is rising.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the world. North America is anticipated to hold a considerable share in the market due to the availability of advanced medications and increased health expenses. Also, awareness among the people about diseases is the major factor that may boost the growth of the market in this region.

The major companies serving the global serine protein kinase market include Novartis AG, Pfizer Inc, Eli Lilly and Co, Bayer AG, AstraZeneca plc, Merck KGaA, and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launches, mergers, and acquisitions, collaborations with the government, and new drug commercialization to stay competitive in the market. For instance, in February 2021, Eli Lilly and Company has entered into a global exclusive license agreement and strategic collaboration with Rigel Pharmaceuticals. The collaboration was aimed to co-develop and commercialize receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor R552 for all indications including autoimmune and inflammatory diseases.

Research Methodology

The market study of the global serine protein market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Serine Protein Kinase Market by Type

2. Global Serine Protein Kinase Market by Application

The Report Covers:

• Comprehensive Research Methodology of the global serine protein market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the market global serine protein market.
• Insights about market determinants that are stimulating the global serine protein market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Serine Protein Kinase Market
• 1.1. Recovery Scenario of Global Serine Protein Kinase Market
• 1.2. Research Methods and Tools
• 1.3. Market Breakdown
  • 1.3.1. By Segments
  • 1.3.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Eli Lilly and Co
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. AstraZeneca plc
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Merck KGaA
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Bayer AG
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Pfizer Inc
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis
• 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

Global Serine Protein Kinase Market by Type

• 4.1.1. AZD-0156
• 4.1.2. AZD-1390
• 4.1.3. KU-55933
• 4.1.4. M-3541
• 4.1.5. Others

Global Serine Protein Kinase Market by Application

4.1.6 Cancer

4.1.7 Adenocarcinoma

4.1.8 Others

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

5.4.1 Latin America

5.4.2 Middle East and Africa

6. Company Profiles

• 6.1. Bristol-Myers Squibb Company
• 6.2. CanBas Co Ltd
• 6.3. Cascadian Therapeutics Inc
• 6.4. CytRx Corporation
• 6.5. Eisai Co Ltd
• 6.6. F. Hoffmann-La Roche Ltd
• 6.7. Genentech Inc
• 6.8. InteRNA Technologies B.V.
• 6.9. Johnson & Johnson Pvt Ltd
• 6.10. Novartis AG
• 6.11. Osi Pharmaceutical Inc
• 6.12. ProNAi Therapeutics Inc
• 6.13. Sareum Holdings Plc
• 6.14. Shuttle Pharmaceutical LLC
• 6.15. Vernalis Plc